Rochester Medical Corporation's CEO Discusses Q3 2012 Results - Earnings Call Transcript

Rochester Medical Corporation (ROCM)

Q3 2012 Earnings Call

July 27, 2012 11:00 a.m. ET

Executives

Anthony J. Conway – President & CEO

David Jonas – CFO

Analysts

Bruce Jackson

Tyson Bauer

Beth Lilly

Larry Haimovitch

Tyson Bauer

Matt Lee

Michael Boulgaris

Presentation

Operator

Good day, ladies and gentlemen, and welcome to the Third Quarter 2012 Rochester Medical Corp. Earnings Conference Call. My name is Jasmine, and I will be your coordinator for today. At this time, all participants are in a listen-only mode, we will be facilitating a question-and-answer session towards the end of today s conference. (Operator s Instructions) As a reminder, this conference is being recorded for replay purposes.

I would now like to turn the presentation over to your host for today s conference Mr. Anthony J. Conway, President and CEO. You may proceed.

Anthony Conway

Good morning. Thank you for joining Rochester Medical s third quarter conference call. I m Jim Conway, the company s President and CEO. And with me is David Jonas, Rochester Medical s Chief Financial Officer.

First, I will provide a brief high level review of our third quarter and Dave will then provide you with more details on our financial results, and then I ll give a quick update on a few items and summarize, and we will take your questions.

Before starting, let me remind you that we will be making some forward-looking statements today, and I would refer you to the Safe Harbor statement found in today s press release and also to the Risk Factors section in the company s Annual Report on Form 10-K for the year ended September 30, 2011. These statements further clarify the risks and uncertainties that are associated with the forward-looking statements.

Okay. In total revenues grew 7% on a reported basis and 10% on a constant currency basis to a total of $15.3 million. Our goal of direct sales business had 9% constant currency growth with the U.S. direct sales business leading the way with a robust 34% increase, paced by good strength in our Home Care market.

If you liked this article you might like

Rochester Medical Corporation Stock Upgraded (ROCM)

Rochester Medical Corporation's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Rochester Medical Corporation Stock Upgraded (ROCM)

Rochester Medical CEO Discusses F1Q2012 Results - Earnings Call Transcript